^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MaaT013

    i
    Associations
    News

    Trials

    Company:
    MaaT Pharma
    Drug class:
    Microbiome modulator
    Related drugs:
    Associations
    News

    Trials

    Apply
    Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (PICASSO) (NCT04988841)
    Phase 2
    Assistance Publique - Hôpitaux de Paris
    Recruiting
    Last update posted :
    09/26/2023
    Initiation :
    01/20/2022
    Primary completion :
    01/20/2024
    Completion :
    06/01/2024
    IL6 • ISG20
    |
    Opdivo (nivolumab) • Yervoy (ipilimumab) • MaaT013